BIIB · Healthcare · $33.0B
After-hours $223.12+0.13%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 19 Drug Manufacturers - General peers
Quarterly Revenue Growth
“성장 제품군 매출이 전 분기 대비 25% 늘어 처음으로 10억 달러를 넘었어요 — 지난 분기 +10%에서 크게 가속됐어요.”
In the company's words · 2026 2분기 earnings call